Many brand name drugs are scheduled to go generic in the next year. Newly developed drugs apply for a patent that protects the company's product from competition for a set time. In the United States a patent filed on a drug lasts for 20 years.
Once the drug patent expires, other companies produce the drug using the same ingredients, and sell it at a much lower price. The population needing the drug now benefits from marketplace competition. Below is a list of brand names drugs about to get competition from generics.
October 2011 Zyprexa olanzapine
November 2011 Lipitor atorvastatin
March 2012 Lexapro excitalopram
March 2012 Seroquel quetiapine
March 2012 Avapro Avalide irbesartan
April 2012 Provigil modafinil
May 2012 Plavix clopidogrel
July 2012 Tricor fenofibrate
August 2012 Singulair montelukast
August 2012 Actos pioglitrazone
September 2012 Diovan valsartan
September 2012 Geodon ziprasidone
November 2012 Lidoderm lidocaine patch
December 2012 Atacand candesartan
March 2013 Lovaza omega 3
August 2013 Temodar temozolomide
Trying the generic version of the brand name drug typically saves the consumer out of pocket money. Home Care Path http://www.homecarepath.com/ in home staff assist seniors with medication reminders.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment